Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Zhenbaodao Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and sale of Traditional Chinese Medicine (TCM) and chemical drugs. The company is particularly well-known for its focus on cardiovascular and cerebrovascular treatments, with flagship products like Shuxuening Injection and Mailuoning Injection. Beyond TCM, Zhenbaodao has expanded its portfolio into chemical generics and is increasingly investing in innovative biologics and high-end medical devices. Headquartered in Harbin, the company operates multiple manufacturing bases and maintains a significant presence in the Chinese domestic market through its integrated industrial chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZHENBAODAO Groups.